Evidence map›Paper›PMID 41509513›Full record

ArticleNAR molecular medicine2026

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase.

Angela Sloan, Calvin J Gordon, Jérémie Prévost, Jonathan Audet, Kathleen Fulton, Emma Woolner, Ming-Hao Chang, Simon M Walker, Egor P Tchesnokov, Kalyan Das and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NAR molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Angela SloanSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
Calvin J GordonDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Jérémie PrévostSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
Jonathan AudetSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
Kathleen FultonSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
Emma WoolnerDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Ming-Hao ChangDepartment of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Molecular Structural and Translational Virology Research Group, KU Leuven, Leuven 3000, Belgium.
Simon M WalkerDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Egor P TchesnokovDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Kalyan DasDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
David SafronetzSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.ORCID https://orcid.org/0000-0002-9024-728X
Matthias GötteDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.ORCID https://orcid.org/0000-0001-6213-5806

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The order

Identifiers

PMID41509513
PMCPMC12776605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.